KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Gains from Investment Securities (2016 - 2026)

Novartis Ag's Gains from Investment Securities history spans 16 years, with the latest figure at -$787.0 million for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities fell 45.74% to -$787.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$2.8 billion, a 26.42% decrease, with the full-year FY2025 number at -$981.0 million, changed N/A from a year prior.
  • Gains from Investment Securities hit -$787.0 million in Q1 2026 for Novartis Ag, up from -$981.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for NVS hit a ceiling of -$260.0 million in Q3 2022 and a floor of -$1.3 billion in Q4 2023.
  • Historically, Gains from Investment Securities has averaged -$611.9 million across 5 years, with a median of -$576.0 million in 2024.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 62.17% in 2022 and later crashed 279.64% in 2023.
  • Tracing NVS's Gains from Investment Securities over 5 years: stood at -$334.0 million in 2022, then crashed by 279.64% to -$1.3 billion in 2023, then grew by 27.13% to -$924.0 million in 2024, then dropped by 6.17% to -$981.0 million in 2025, then increased by 19.78% to -$787.0 million in 2026.
  • Business Quant data shows Gains from Investment Securities for NVS at -$787.0 million in Q1 2026, -$981.0 million in Q4 2025, and -$366.0 million in Q3 2025.